US Stock Insider Trading | GeneDx Holdings disclosed 6 insider transactions on March 17

K-LinePoet · 2026-04-02T03:03:51+00:00

On March 17, 2026, GeneDx Holdings disclosed multiple insider transactions, including sales by director Stueland Katherine and executive Feeley Kevin, involving a total of 11,227 shares valued at hundreds of thousands of dollars. The company focuses on improving healthcare through a data-driven health intelligence platform.

K-LinePoet

2026-04-02 03:03:51

Abstract generation in progress

On March 17, 2026, GeneDx Holdings (WGS) disclosed six transactions involving company insiders.

Director Stueland Katherine sold 9,229 shares on March 16, 2026.

【Recent Insider Transactions】

Disclosure date	Position	Name	Transaction date	Buy/Sell	Shares	Price per share/US$	Total amount/US$
March 17, 2026	Executive	Feeley Kevin	March 16, 2026	Sold	3065	77.05	236,200
March 17, 2026	Executive	Feeley Kevin	March 16, 2026	Sold	2384	76.35	182,000
March 17, 2026	Executive	Feeley Kevin	March 16, 2026	Sold	257	77.94	20,000
March 17, 2026	Director	Stueland Katherine	March 16, 2026	Sold	7178	76.35	548,000
March 17, 2026	Director	Stueland Katherine	March 16, 2026	Sold	9229	77.05	711,100
March 17, 2026	Director	Stueland Katherine	March 16, 2026	Sold	772	77.94	60,200
March 11, 2026	Executive	Feeley Kevin	March 9, 2026	Sold	1280	86.75	111,000
March 11, 2026	Director	Stueland Katherine	March 9, 2026	Sold	3678	86.75	319,100
March 9, 2026	Executive	Feeley Kevin	March 6, 2026	Bought	1986	88.11	175,000
March 9, 2026	Director	Stueland Katherine	March 6, 2026	Bought	3404	88.11	299,900

【Company Information】

GeneDx Holdings Corp. is a company incorporated in Delaware on July 10, 2020. Sema4 is a patient-centered health intelligence company that is committed to advancing healthcare through data-driven insights. Sema4 builds dynamic models of human health and defines the best personalized health trajectories by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data, thereby transforming healthcare. Centrellis is their innovative health intelligence platform that enables a more comprehensive understanding of diseases and health and provides science-driven solutions for the most urgent medical needs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.